SCHEMBL20150852

SCHEMBL20150852

COc1c(C)ccc(/C=N/O)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 3/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 5/20 0.37
HPGD P15428 5/20 0.37
HTT P42858 3/20 0.37
ALDH1A1 P00352 6/20 0.36
MAPT P10636 4/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FGF23 Q9GZV9 1/20 0.33
GAA P10253 1/20 0.32
CYP1A2 P05177 2/20 0.32
USP2 O75604 1/20 0.32
NR3C1 P04150 1/20 0.31
HSD17B10 Q99714 2/20 0.31
CYP3A4 P08684 1/20 0.31
PKM P14618 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPK1 P28482 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148177 1.00 L3MBTL1 (0.39) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL18502965 0.81 KDM4E (0.44) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL18508561 0.81 KDM4E (0.44) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL18502962 0.80 HPGD (0.38) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL18508559 0.80 HPGD (0.38) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL20148179 0.78 HPGD (0.37) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL20150803 0.78 HPGD (0.37) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL29209752 0.77 HPGD (0.38) L3MBTL1KDM4EKMT2ALMNAHPGD
SCHEMBL20136310 0.77 CA1 (0.42) L3MBTL1KDM4EKMT2AALDH1A1TSHR
SCHEMBL30881655 0.77 HPGD (0.38) L3MBTL1KDM4EKMT2ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors AXOVANT SCIENCES GMBH (CH) 2019-08-06 US disclosed
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 L3MBTL1 3046/4885KDM4E 2804/4885KMT2A 1703/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 L3MBTL1 3492/4885KDM4E 3741/4885KMT2A 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.